Mokksha Management Services Profile
Key Indicators
- Authorised Capital ₹ 3.20 M
as on 09-07-2024
- Paid Up Capital ₹ 3.16 M
as on 09-07-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 8.49%
(FY 2020)
- Profit 70.45%
(FY 2020)
- Ebitda 69.79%
(FY 2020)
- Net Worth -21.79%
(FY 2020)
- Total Assets 6.42%
(FY 2020)
About Mokksha Management Services
The Corporate was formerly known as Mokksha Pharma Consultancy Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.20 M and a paid-up capital of Rs 3.16 M, as per Ministry of Corporate Affairs (MCA) records.
Pondavakkam Arunodhayan and Pondahavakkam Priya serve as directors at the Company.
- CIN/LLPIN
U74140TN2013PTC093364
- Company No.
093364
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mokksha Management Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pondavakkam Arunodhayan  | Director | 17-Oct-2013 | Current |
| Pondahavakkam Priya | Director | 17-Oct-2013 | Current |
Financial Performance of Mokksha Management Services.
Mokksha Management Services Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 8.49% increase. The company also saw a substantial improvement in profitability, with a 70.45% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mokksha Management Services?
In 2019, Mokksha Management Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hubra Pharmaceuticals Private LimitedActive 8 years 9 monthsPondavakkam Arunodhayan and Pondahavakkam Priya are mutual person
3G Surgical Industries Private LimitedActive 5 years 11 monthsPondavakkam Arunodhayan and Pondahavakkam Priya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mokksha Management Services?
Unlock and access historical data on people associated with Mokksha Management Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mokksha Management Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mokksha Management Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
